The prevention and management of alloimmunization in sickle cell disease: The benefit of extended phenotypic matching of red blood cells

Immunohematology

Volumn 28, Issue 1, 2012, Pages 20-23

  Vichinsky, Elliott P ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALLOANTIBODY; CYTOKINE; ERYTHROCYTE ANTIGEN; ERYTHROPOIETIN; HEMOGLOBIN; HEMOGLOBIN S; IMMUNOGLOBULIN; RITUXIMAB; STEROID;

ALLOIMMUNIZATION; APHERESIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP TYPING; BLOOD TRANSFUSION REACTION; CLINICAL PROTOCOL; COOMBS TEST; DRUG MEGADOSE; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GENOTYPE; HUMAN; LEUKAPHERESIS; PHENOTYPE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THALASSEMIA;

ANEMIA, SICKLE CELL; AUTOANTIBODIES; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; CALIFORNIA; CHILD; ERYTHROCYTE TRANSFUSION; HOSPITALS; HUMANS; ISOANTIBODIES; MINORITY GROUPS; PROGRAM DEVELOPMENT;

EID: 84862550891     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
2. Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 1997;89:1533-42.
3. Hulbert ML, Scothorn DJ, Panepinto JA, et al. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 2006;149:710-12.
4. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369-73.
5. Wahl S, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion, 2012. In press.
6. Afenyi-Annan A, Willis MS, Konrad TR, Lottenberg R. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007;47:2089-97.
7. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.
8. Hoppe C, Klitz W, Vichinsky E, Styles L. HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 2009;84:462-4.
9. Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007;317:627-9.
10. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431-7.
11. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group [see comments]. N Engl J Med 1995;333:206-13.
12. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
13. Allen TI, Billingsley K, Slaughter J, et al. Red cell genotyping: a cost effective approach to screening large numbers of donors [abstract]. Transfusion 2009;49(Suppl):135A.
14. Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J Jr, Castilho L. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009;97:147-52.
15. Wilkinson K, Harris S, Gaur P, et al. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion 2012;52:381-8.
16. Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50:13-19.
17. Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 2004;44:67-72.
18. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006;46:105-10.
19. Win N, New H, Lee E, de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008;48:1231-8.
20. Bachmeyer C, Maury J, Parrot A, et al. Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol 2010;85:91-2.
21. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94-8.
22. Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732-9.
23. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190-3.
24. Ambruso DR, Pallas C, Dickey W, et al. Prevention of alloimmunization in sickle cell disease: update on a successful and cost-effective regional program [abstract]. Presented at the 20th Meeting of the National Sickle Cell Disease Program. Boston, MA, March 18-21, 1995.